<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are a group of disorders characterized by peripheral <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> despite normo- or hyper-cellular bone marrow </plain></SENT>
<SENT sid="1" pm="."><plain>This is thought to be due to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of hematopoietic bone marrow cells, resulting in ineffective hematopoiesis </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein (hnRNP) B1 is involved in pre-<z:chebi fb="2" ids="33699">mRNA</z:chebi> processing and binds to telomeric cDNA repeats </plain></SENT>
<SENT sid="3" pm="."><plain>The hnRNP B1 is a marker for early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of our study was to clarify the relationships between prognosis and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, telomerase activity (TA) and hnRNP expression in the bone marrow </plain></SENT>
<SENT sid="5" pm="."><plain>The subjects were 51 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, including patients with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA) (n = 32), <z:hpo ids='HP_0004828'>refractory anemia with ringed sideroblasts</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>) (n = 1), <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) (n = 7), <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t) (n = 8) and <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (CMMoL) (n = 3) </plain></SENT>
<SENT sid="6" pm="."><plain>We also studied 6 cases with <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) arising from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and 10 control subjects </plain></SENT>
<SENT sid="7" pm="."><plain>Bone marrow biopsies were stained immunohistochemically for caspase-3 (marker of apoptotic activity) and human telomerase reverse transcriptase (hTERT), and hnRNP B1 </plain></SENT>
<SENT sid="8" pm="."><plain>Fatal <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> was the cause of <z:hpo ids='HP_0011420'>death</z:hpo> in 19 of the 51 patients </plain></SENT>
<SENT sid="9" pm="."><plain>The caspase-3 positive cell rate was higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (16.3%) than in controls (4.4%) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (0.5%) </plain></SENT>
<SENT sid="10" pm="."><plain>The percentage of hnRNP B1-positive cells was higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (15.3%) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (56.3%) than in controls (5.6%) </plain></SENT>
<SENT sid="11" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, hnRNP B1 levels were higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t subtypes than in RA and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>The percentage of hTERT-positive cells was higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (50.0%) than in controls (20.2%) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (23.6%) </plain></SENT>
<SENT sid="13" pm="."><plain>Our findings suggest that activation of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> occurs in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in the absence of hTERT expression, implicating high <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the absence of high TA with ineffective hematopoiesis </plain></SENT>
<SENT sid="14" pm="."><plain>Poor prognosis correlated with higher caspase-3 and lower hTERT rates </plain></SENT>
<SENT sid="15" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, hnRNP B1 activity may be associated with leukemic transformation </plain></SENT>
</text></document>